Trial Profile
Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome treated with percutaneous coronary intervention
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Dec 2015
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Prasugrel (Primary)
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- 09 Dec 2015 New trial record